Transcend Capital Advisors, LLC Medtronic PLC Transaction History

Transcend Capital Advisors, LLC

  • $1.35 Billion
  • Q4 2024

A detailed history of Transcend Capital Advisors, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 61,911 shares of MDT stock, worth $5.57 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
61,911
Previous 71,555 13.48%
Holding current value
$5.57 Million
Previous $6.44 Million 23.24%
% of portfolio
0.37%
Previous 0.45%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025
SELL
$79.61 - $92.24 $767,758 - $889,562
-9,644 Reduced 13.48%
61,911 $4.95 Million
Q3 2024

Oct 15, 2024
SELL
$76.84 - $91.03 $28,738 - $34,045
-374 Reduced 0.52%
71,555 $6.44 Million
Q2 2024

Jul 02, 2024
BUY
$78.71 - $87.02 $174,657 - $193,097
2,219 Added 3.18%
71,929 $5.66 Million
Q1 2024

May 03, 2024
BUY
$82.84 - $88.09 $674,317 - $717,052
8,140 Added 13.22%
69,710 $6.08 Million
Q4 2023

Feb 05, 2024
BUY
$69.43 - $83.43 $229,396 - $275,652
3,304 Added 5.67%
61,570 $5.07 Million
Q3 2023

Oct 31, 2023
BUY
$78.22 - $90.4 $1.69 Million - $1.96 Million
21,635 Added 59.06%
58,266 $4.57 Million
Q2 2023

Jul 13, 2023
SELL
$79.47 - $91.38 $62,304 - $71,641
-784 Reduced 2.1%
36,631 $3.23 Million
Q1 2023

Apr 12, 2023
BUY
$76.72 - $87.58 $476,124 - $543,521
6,206 Added 19.89%
37,415 $3.02 Million
Q4 2022

Jan 20, 2023
SELL
$76.18 - $87.74 $444,053 - $511,436
-5,829 Reduced 15.74%
31,209 $0
Q3 2022

Oct 17, 2022
SELL
$80.75 - $95.31 $341,007 - $402,494
-4,223 Reduced 10.23%
37,038 $2.99 Million
Q2 2022

Jul 12, 2022
SELL
$87.4 - $113.09 $858,879 - $1.11 Million
-9,827 Reduced 19.24%
41,261 $3.7 Million
Q1 2022

Apr 20, 2022
BUY
$100.58 - $112.38 $345,794 - $386,362
3,438 Added 7.22%
51,088 $5.67 Million
Q4 2021

Jan 20, 2022
BUY
$99.53 - $127.75 $459,928 - $590,332
4,621 Added 10.74%
47,650 $4.93 Million
Q3 2021

Nov 04, 2021
BUY
$122.75 - $135.17 $5.28 Million - $5.82 Million
43,029 New
43,029 $5.34 Million
Q2 2021

Aug 13, 2021
SELL
$118.19 - $131.5 $5.12 Million - $5.69 Million
-43,295 Closed
0 $0
Q1 2021

May 12, 2021
SELL
$111.18 - $119.74 $180,333 - $194,218
-1,622 Reduced 3.61%
43,295 $5.12 Million
Q4 2020

Feb 12, 2021
BUY
$100.57 - $117.14 $1.06 Million - $1.24 Million
10,553 Added 30.71%
44,917 $5.26 Million
Q3 2020

Nov 13, 2020
BUY
$90.13 - $108.78 $1.55 Million - $1.87 Million
17,193 Added 100.13%
34,364 $3.57 Million
Q2 2020

Aug 05, 2020
SELL
$84.11 - $103.33 $122,884 - $150,965
-1,461 Reduced 7.84%
17,171 $1.58 Million
Q1 2020

May 08, 2020
BUY
$72.92 - $121.3 $11,302 - $18,801
155 Added 0.84%
18,632 $1.69 Million
Q4 2019

Feb 19, 2020
BUY
$104.49 - $114.54 $1.93 Million - $2.12 Million
18,477 New
18,477 $2.1 Million

Others Institutions Holding MDT

# of Institutions
2,350
Shares Held
1.05B
Call Options Held
7M
Put Options Held
7.22M
View Full List

About Medtronic plc

MDT Quotes by TradingView
  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $120B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Transcend Capital Advisors, LLC Portfolio

Follow Transcend Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email